Global Neurovascular Embolectomy Device Market, By Product Type (Aspiration Systems and Stent Retrieval Systems), By Application (Hospital, Medical Center, and Others), and By Region (North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, and Rest of the World) – Market Size & Forecasting (2016-2028)

Neurovascular Embolectomy Device Market growth is expected to gain high momentum during the forecast period due to rising expenditure capacity and increasing knowledge of consumers. Embolectomy is the emergency surgical procedure for the removal of emboli, which blocks blood circulation. An embolus is an unattached mass that travels in the bloodstream and can clog arterial capillary beds at a point different from its origin. Embolectomy is usually used as a last resort. Procedures such as thrombolysis and anticoagulation are more frequently carried out. Doctors want to use instruments and techniques that offer a higher window for stroke treatment with a high success rate and minimal post-surgical impact. This can be attributed to the increasing demand for bare platinum coils as compared to coated coils. The cost of coated coils is higher as compared to bare platinum coils. Additionally, stroke treatment involves high healthcare expenditure that drives the focus on the development of economical treatment techniques. The neurovascular embolectomy device market is driven by the increasing cases of strokes, innovation and product development, international trade, and rising consumer awareness about strokes.

Globally, the expenditure capacity of consumers has risen. Superior healthcare treatment with better devices that offer improved success rates has led to the rise in the adoption of neurovascular embolectomy devices. Moreover, growing consumer knowledge for post-surgery safety has increased the application of apt devices suitable for the treatment. Hence, rising expenditure capacity and increasing knowledge of consumers are fueling the growth of the neurovascular embolectomy devices market. Furthermore, elevated incidences of reinstating blood flow, along with high success rates of functional independence among patients also support market growth. Conversely, scarcity of skilled doctors and insufficient reimbursements in developing nations are key factors restraining the growth of the market. Furthermore, there are stringent regulations that device manufacturers and user facilities must adhere to.

North America is leading the neurovascular embolectomy devices market. According to the US Centers for Disease Control and Prevention (CDC), stroke is the third leading cause of deaths in the US. Approximately 1 million people in the US are affected by strokes annually, out of which, approximately 140,000 people die.

Key Factors Impacting Market Growth:

  • High stroke rates
  • Rising expenditure capacity and increasing knowledge of consumers
  • Scarcity of skilled doctors and insufficient reimbursements 

Regional Outlook:

North America, Western Europe, and Asia Pacific by region are estimated to dominate the neurovascular embolectomy device market during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, the government policies have been favorable for the growth of the healthcare infrastructure in these regions. North America and Western Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for neurovascular embolectomy device market during the forecast period. 

The US, Germany, France, UK, Canada, and Spain have been some the major markets in the region. Asia Pacific is estimated to register one of highest CAGR for neurovascular embolectomy device market during the forecast period. This region has witnessed strategic investments by global companies to cater the growing demand in the recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for neurovascular embolectomy device market in the region. Other regions including Middle East, Eastern Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets for neurovascular embolectomy device during the forecast period.

Companies Covered: LeMaitre Vascular Inc., iVascular SLU, Boston Scientific Corporation, Medtronic, Teleflex Inc., Cook Medical, Straub Medical AG, DePuy Synthes, Edwards Lifesciences Corporation…

Market Segmentation:

By Product Type:

  • Aspiration Systems
  • Stent Removal Systems

By Application:

  • Hospital
  • Medical Center
  • Others

By Region:

  • North America
    • By Country (US, Canada, Mexico)
    • By Product Type
    • By Application
  • Western Europe
    • By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)
    • By Product Type
    • By Application
  • Eastern Europe
    • By Country (Russia, Turkey, Rest of Eastern Europe)
    • By Product Type
    • By Application
  • Asia Pacific
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Product Type
    • By Application
  • Middle East
    • By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)
    • By Product Type
    • By Application
  • Rest of the World
    • By Region (South America, Africa)
    • By Product Type
    • By Application

Reasons to Buy This Report:

  • Market size estimation of the global neurovascular embolectomy market on a regional and global basis
  • The unique research design for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: sales@quincemarketinsights.com